Treating RPE cells with the iron chelator deferoxamine (DFO) can lead to a reduction in intracellular iron ions (154), an increase in genes related to iron transport, a significant elevation in the level of hypoxia-inducible factor HIF2, and impairment of mitochondrial function, indicating that the RPE is the main target tissue for DFO toxicity, resulting in atrophy and degeneration of the RPE and posing a risk of retinal detachment
Talk to a pro: Dont rely on internet anecdotesbring your concerns to a licensed medical provider who can help you craft a safe plan
Noom mines moments of motivation, moments like New Years, to transform the choice landscape so that a monks mindset is not a requirement to sustain healthy habits
If that happens, your options include switching to brand-name products (potentially through insurance), finding another compounding pharmacy that maintains legal authority to compound, or discussing alternative weight management approaches with your provider